Point72 Hong Kong’s NEVRO CORP. NVRO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-2,350
Closed -$170K 2488
2022
Q1
$170K Buy
+2,350
New +$169K 0.01% 1015
2021
Q4
Sell
-526
Closed -$61K 2486
2021
Q3
$61K Sell
526
-812
-61% -$106K ﹤0.01% 1476
2021
Q2
$222K Buy
1,338
+957
+251% +$149K 0.01% 1131
2021
Q1
$53K Buy
+381
New +$62.2K ﹤0.01% 1276
2020
Q3
Sell
-356
Closed -$43K 1593
2020
Q2
$43K Buy
+356
New +$42.2K ﹤0.01% 762
2019
Q1
Sell
-266
Closed -$10K 1328
2018
Q4
$10K Sell
266
-71
-21% -$3.16K ﹤0.01% 553
2018
Q3
$19K Buy
+337
New +$21.1K 0.01% 605
2017
Q2
Sell
-49
Closed -$5K 1061
2017
Q1
$5K Sell
49
-91
-65% -$8.24K 0.01% 573
2016
Q4
$10K Buy
140
+40
+40% +$3.42K 0.01% 657
2016
Q3
$10K Buy
+100
New +$9.03K 0.01% 649

Other funds holding NVRO

Point72 Hong Kong's NVRO Position: Q2 2022 in Review

Point72 Hong Kong sold out of NEVRO CORP. (NVRO) in Q2 2022, closing a stake of 2,350 shares — an estimated $170K sold.

Point72 Hong Kong first reported a position in NVRO in Q3 2016 and held it in 10 quarters. The position peaked at $222K in Q2 2021. 175 funds tracked by Wall St. Rank hold NVRO as of Q2 2022.

  • Point72 Hong Kong reported no remaining NEVRO CORP. position as of Q2 2022 after selling out during the quarter.
  • Point72 Hong Kong sold 2,350 NEVRO CORP. shares in Q2 2022, an estimated $170K.
  • Point72 Hong Kong first reported a position in NEVRO CORP. in Q3 2016 and held it in 10 quarters.
  • Point72 Hong Kong's NEVRO CORP. position peaked at $222K in Q2 2021.
  • 175 funds tracked by Wall St. Rank held NEVRO CORP. as of Q2 2022.

Based on Point72 Hong Kong's 13F filing for Q2 2022, filed 15 Aug 2022.